|Comprehensive genomic characterization defines human glioblastoma genes and core pathways|
Cancer Genome Atlas Research Network
Nature 455 (7216), 1061, 2008
|Exciting new advances in neuro‐oncology: the avenue to a cure for malignant glioma|
EG Van Meir, CG Hadjipanayis, AD Norden, HK Shu, PY Wen, JJ Olson
CA: a cancer journal for clinicians 60 (3), 166-193, 2010
|The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline|
ME Linskey, DW Andrews, AL Asher, SH Burri, D Kondziolka, ...
Journal of neuro-oncology 96 (1), 45-68, 2010
|A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant …|
EA Chiocca, KM Abbed, S Tatter, DN Louis, FH Hochberg, F Barker, ...
Molecular Therapy 10 (5), 958-966, 2004
|The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline|
SN Kalkanis, D Kondziolka, LE Gaspar, SH Burri, AL Asher, CS Cobbs, ...
Journal of neuro-oncology 96 (1), 33-43, 2010
|The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline|
LE Gaspar, MP Mehta, RA Patchell, SH Burri, PD Robinson, RE Morris, ...
Journal of neuro-oncology 96 (1), 17-32, 2010
|Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification.|
AJ Ekstrand, N Longo, ML Hamid, JJ Olson, L Liu, VP Collins, CD James
Oncogene 9 (8), 2313-2320, 1994
|The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline|
TC Ryken, M McDermott, PD Robinson, M Ammirati, DW Andrews, ...
Journal of neuro-oncology 96 (1), 103-114, 2010
|A phase II trial of temozolomide for patients with recurrent or progressive brain metastases|
LE Abrey, JD Olson, JJ Raizer, M Mack, A Rodavitch, DY Boutros, ...
Journal of neuro-oncology 53 (3), 259-265, 2001
|Comprehensive community-and school-based interventions to prevent antisocial behavior.|
RF Catalano, MW Arthur, DJ Hawkins, L Berglund, JJ Olson
Sage Publications, Inc, 1998
|Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury|
S Cheng, AS Pollock, R Mahimkar, JL Olson, DH Lovett, S Cheng, ...
The FASEB journal 20 (11), 1898-1900, 2006
|Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation|
D Yan, WL Ng, X Zhang, P Wang, Z Zhang, YY Mo, H Mao, C Hao, ...
PloS one 5 (7), e11397, 2010
|Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines|
J He, JJ Olson, CD James
Cancer research 55 (21), 4833-4836, 1995
|Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway|
C Tan, RG de Noronha, AJ Roecker, B Pyrzynska, F Khwaja, Z Zhang, ...
Cancer research 65 (2), 605-612, 2005
|The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline|
MP Mehta, NA Paleologos, T Mikkelsen, PD Robinson, M Ammirati, ...
Journal of neuro-oncology 96 (1), 71-83, 2010
|Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes|
CE Junge, CJ Lee, KB Hubbard, Z Zhang, JJ Olson, JR Hepler, DJ Brat, ...
Experimental neurology 188 (1), 94-103, 2004
|Hormonal manipulation of meningiomas in vitro|
JJ Olson, DW Beck, J Schlechte, PM Loh
Journal of neurosurgery 65 (1), 99-107, 1986
|The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline|
M Ammirati, CS Cobbs, ME Linskey, NA Paleologos, TC Ryken, SH Burri, ...
Journal of neuro-oncology 96 (1), 85-96, 2010
|Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity|
Y Rong, VE Belozerov, C Tucker-Burden, G Chen, DL Durden, JJ Olson, ...
Cancer research 69 (6), 2540-2549, 2009
|Glial cells influence membrane-associated enzyme activity at the blood-brain barrier|
DW Beck, RL Roberts, JJ Olson
Brain research 381 (1), 131-137, 1986